Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

J&J collaborates on consumer health device accelerator

Partners with Shenzhen-based investor firm HAX

Johnson & Johnson (J&J)

Johnson & Johnson is working with Shenzhen-based investor firm HAX on an accelerator programme for novel consumer health devices.

The firm's Johnson & Johnson Innovation arm will work with HAX on supporting start-ups that are developing technologies in areas such as skin care, baby care and wound care.

The world's largest hardware accelerator with bases in Silicon Valley and south east China, HAX has a specific health track within its Shenzhen hardware accelerator.

Companies that have successfully applied to its spring 2017 call for entries and are then co-selected by HAX and J&J will receive mentorship in business development and commercialization from Johnson & Johnson Innovation executives.

They will also, HAX said, learn how to align their products with Johnson & Johnson's consumer health care portfolio.

6th January 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics